Cresset Asset Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$586K Sell
14,544
-248
-2% -$9.27K ﹤0.01% 993
2025
Q4
$515K Buy
14,792
+839
+6% +$65.9K ﹤0.01% 1056
2025
Q3
$1.16M Sell
13,953
-1,064
-7% -$77K 0.01% 694
2025
Q2
$1.1M Sell
15,017
-77,788
-84% -$5.64M 0.01% 659
2025
Q1
$10.6M Sell
92,805
-7,170
-7% -$436K 0.05% 215
2024
Q4
$5.04M Buy
99,975
+18,865
+23% +$988K 0.02% 350
2024
Q3
$3.75M Buy
81,110
+2,941
+4% +$105K 0.01% 533
2024
Q2
$2.54M Buy
78,169
+8,079
+12% +$221K 0.01% 619
2024
Q1
$1.77M Buy
+70,090
New +$1.66M 0.01% 707
2019
Q2
Sell
-159
Closed -$2K 716
2019
Q1
$2K Sell
159
-19
-11% -$236 ﹤0.01% 1621
2018
Q4
$2K Buy
+178
New +$2.35K ﹤0.01% 1284

Other funds holding CORT